DONNA CAULFIELD: Open Payments
NPI 1598147597 · BRANSON WEST, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 35 payments from 12 companies in 2025. Trend: 2023 $138 · 2024 $491 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $177 |
| Abbott Laboratories | 7 | $172 |
| Lilly USA, LLC | 5 | $89 |
| Novo Nordisk Inc | 4 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Globus Medical, Inc. | 1 | $32 |
| Astellas Pharma US Inc | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: FREESTYLE LIBRE, BREZTRI, Ozempic, MOUNJARO, JARDIANCE, XIFAXAN, Senza, Veozah.
Industry payments across MO — which companies pay providers there.
